‘Patients will suffer’: tales from the frontline of the UK pharma crisis
NegativeFinancial Markets

The ongoing pricing standoff between the UK government and pharmaceutical companies is causing significant disruptions in research and threatening thousands of jobs. Chancellor Rachel Reeves has called for increased investment in the UK, indicating a willingness to raise drug prices for the NHS. This situation is critical as it not only affects the pharmaceutical industry but also has serious implications for patient care and the future of healthcare in Britain.
— Curated by the World Pulse Now AI Editorial System












